Russia's BBIT Coating Announcement: Separate Film Protection from In-Can Preservation
A Russian BBIT announcement identifies a film-protection offer. Keep cured-coating evidence separate from wet-paint preservation and resolve dose documents.
A Russian facade-coating biocide announcement raises a practical formulation question: which material state is being protected? A claim about the coating on a wall cannot, by itself, justify reducing preservation of the wet paint in its container.
What the October announcement establishes
On 15 October 2026, Soyuzkraska reported Neohim's Neomikon BBIT offer for protecting formed facade coatings against fungi and algae. The association identifies the product as a film biocide and distinguishes it from an in-can preservative.
Neohim's film-biocide catalogue also lists BBIT, and separately recommends in-can preservation for water-dispersion materials. These sources establish the intended role of the announced offer. They do not independently verify its durability, environmental safety or an application result in a MOS formulation.
For Russian coating developers, this is a specific candidate technology to investigate. Its relevance does not require pretending that MOS sells the brand or that another additive is already an equivalent.
Two protection tasks need two acceptance records
The wet product and the cured exterior film encounter different conditions. Keep their evidence separate when reviewing a new additive proposal.
| Protection task | Material state and exposure | Evidence to request |
|---|---|---|
| Preservation in the container | The actual wet paint during its intended storage and handling | Evidence for that formulation, package and preservation programme |
| Protection of the formed coating | The cured film under its intended exterior exposure | Evidence on the relevant coating system, substrate, conditioning and exposure |
A favourable dry-film result cannot be relabelled as wet-paint shelf-life evidence. Conversely, acceptable stored paint does not establish resistance of the exposed coating to fungal or algal attack. A formulation change affecting both tasks should identify both assessment endpoints.
In particular, do not reduce a separate in-can component solely because the announcement suggests that the film biocide can lower preservative demand. First obtain evidence that the actual wet formulation remains adequately protected under its intended conditions. This article reports no MOS test or validated reduction.
Resolve the product document before changing the formulation
The association article and the manufacturer's current catalogue present different addition ranges. This review adopts neither range as an instruction. Averaging them—or selecting the lower one for a cost comparison—would conceal the unresolved document and application basis.
Ask the manufacturer to identify the exact grade, current document revision, applicable formulation and basis of any recommendation. Define the proposed trial with the reference paint, incorporation conditions and acceptance requirements visible. Keep compatibility observations distinct from proof of long-term exterior protection.
The MOS coating-additives category is a route for an actual formulation enquiry. State whether the task concerns wet-product preservation, formed-film protection or both. The category does not establish Neomikon distribution, a MOS BBIT offer, an approved dose or equivalent performance.